Soleus Capital Management, L.P. - Q3 2020 holdings

$189 Million is the total value of Soleus Capital Management, L.P.'s 63 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 45.9% .

 Value Shares↓ Weighting
EPIX SellESSA PHARMA INC$12,606,000
-2.3%
1,826,980
-12.3%
6.68%
-9.2%
QDEL SellQUIDEL CORP$6,746,000
-2.4%
30,751
-0.5%
3.58%
-9.3%
IMMU SellIMMUNOMEDICS INC$6,485,000
+53.8%
76,268
-35.9%
3.44%
+43.0%
NVCR SellNOVOCURE LTD$5,830,000
+74.3%
52,377
-7.1%
3.09%
+62.1%
IRMD SellIRADIMED CORP$4,249,000
-13.8%
198,739
-6.4%
2.25%
-19.9%
ZYME SellZYMEWORKS INC$4,156,000
-72.6%
89,233
-78.8%
2.20%
-74.5%
EIGR SellEIGER BIOPHARMACEUTICALS INC$3,847,000
-35.4%
472,558
-23.8%
2.04%
-39.9%
ALXN SellALEXION PHARMACEUTICALS INC$3,442,000
-39.6%
30,077
-40.8%
1.82%
-43.8%
DXCM SellDEXCOM INC$3,126,000
-19.2%
7,583
-20.6%
1.66%
-24.9%
ZYXI SellZYNEX INC$2,060,000
-53.1%
118,047
-33.1%
1.09%
-56.4%
NVRO SellNEVRO CORP$1,661,000
-26.0%
11,926
-36.6%
0.88%
-31.2%
IONS SellIONIS PHARMACEUTICALS INC$932,000
-56.6%
19,648
-46.0%
0.49%
-59.6%
STAA SellSTAAR SURGICAL CO$868,000
-30.9%
15,346
-24.9%
0.46%
-35.8%
PODD SellINSULET CORP$859,000
+10.6%
3,632
-9.2%
0.46%
+2.7%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$853,000
-32.5%
10,200
-40.7%
0.45%
-37.3%
PCRX SellPACIRA BIOSCIENCES$613,000
-4.2%
10,200
-16.4%
0.32%
-11.0%
AZN SellASTRAZENECA PLCsponsored adr$504,000
-93.0%
9,203
-93.2%
0.27%
-93.5%
FATE SellFATE THERAPEUTICS INC$388,000
-65.7%
9,712
-70.6%
0.21%
-68.1%
CSTL SellCASTLE BIOSCIENCES INC$323,000
-42.8%
6,269
-58.2%
0.17%
-46.9%
CNST SellCONSTELLATION PHARMCETICLS I$218,000
-78.3%
10,742
-67.8%
0.12%
-79.7%
ARVN ExitARVINAS INC$0-6,000
-100.0%
-0.12%
RLMD ExitRELMADA THERAPEUTICS INC$0-6,900
-100.0%
-0.18%
RAPT ExitRAPT THERAPEUTICS INC$0-15,100
-100.0%
-0.25%
INSP ExitINSPIRE MED SYS INC$0-5,608
-100.0%
-0.28%
ATRS ExitANTARES PHARMA INC$0-229,046
-100.0%
-0.36%
MASI ExitMASIMO CORP$0-3,400
-100.0%
-0.44%
VAPO ExitVAPOTHERM INC$0-21,700
-100.0%
-0.51%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-14,000
-100.0%
-0.58%
SILK ExitSILK RD MED INC$0-27,711
-100.0%
-0.66%
FOLD ExitAMICUS THERAPEUTICS INC$0-127,300
-100.0%
-1.09%
HUM ExitHUMANA INC$0-6,600
-100.0%
-1.46%
ABBV ExitABBVIE INC$0-28,900
-100.0%
-1.62%
NARI ExitINARI MED INC$0-65,817
-100.0%
-1.82%
LLY ExitLILLY ELI & CO$0-20,800
-100.0%
-1.95%
AGLE ExitAEGLEA BIOTHERAPEUTICS INC$0-369,852
-100.0%
-1.95%
PRTA ExitPROTHENA CORP PLC$0-674,603
-100.0%
-4.02%
ZYME ExitZYMEWORKS INCput$0-327,900
-100.0%
-6.74%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ESSA PHARMA INC16Q3 202310.8%
IRADIMED CORP16Q3 20235.8%
XENON PHARMACEUTICALS INC15Q3 20232.9%
IVERIC BIO INC14Q1 20236.5%
SURMODICS INC14Q3 20234.7%
NATERA INC13Q3 20233.9%
DEXCOM INC13Q2 20234.2%
NOVOCURE LTD13Q3 20233.4%
CRISPR THERAPEUTICS AG13Q2 20232.6%
LYRA THERAPEUTICS INC13Q3 20231.0%

View Soleus Capital Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Soleus Capital Management, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (188649000.0 != 188647000.0)

Export Soleus Capital Management, L.P.'s holdings